|
1
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Saha SK, Zhu AX, Fuchs CS and Brooks GA:
Forty-Year trends in cholangiocarcinoma incidence in the U.S.:
Intrahepatic disease on the rise. Oncologist. 21:594–599.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rizvi S, Khan SA, Hallemeier CL, Kelley RK
and Gores GJ: Cholangiocarcinoma-evolving concepts and therapeutic
strategies. Nat Rev Clin Oncol. 15:95–111. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Razumilava N and Gores GJ: Combination of
gemcitabine and cisplatin for biliary tract cancer: A platform to
build on. J Hepatol. 54:577–578. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
DeOliveira ML, Cunningham SC, Cameron JL,
Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ and Schulick
RD: Cholangiocarcinoma: Thirty-one-year experience with 564
patients at a single institution. Ann Surg. 245:755–762.
2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Welzel TM, Mellemkjaer L, Gloria G, Sakoda
LC, Hsing AW, El Ghormli L, Olsen JH and McGlynn KA: Risk factors
for intrahepatic cholangiocarcinoma in a low-risk population: A
nationwide case-control study. Int J Cancer. 120:638–641.
2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Donato F, Gelatti U, Tagger A, Favret M,
Ribero ML, Callea F, Martelli C, Savio A, Trevisi P and Nardi G:
Intrahepatic cholangiocarcinoma and hepatitis C and B virus
infection, alcohol intake, and hepatolithiasis: A case-control
study in Italy. Cancer Causes Control. 12:959–964. 2001.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tyson GL and El-Serag HB: Risk factors for
cholangiocarcinoma. Hepatology. 54:173–184. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Palmer WC and Patel T: Are common factors
involved in the pathogenesis of primary liver cancers? A
meta-analysis of risk factors for intrahepatic cholangiocarcinoma.
J Hepatol. 57:69–76. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Charatcharoenwitthaya P, Enders FB,
Halling KC and Lindor KD: Utility of serum tumor markers, imaging,
and biliary cytology for detecting cholangiocarcinoma in primary
sclerosing cholangitis. Hepatology. 48:1106–1117. 2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Patel AH, Harnois DM, Klee GG, LaRusso NF
and Gores GJ: The utility of CA 19-9 in the diagnoses of
cholangiocarcinoma in patients without primary sclerosing
cholangitis. Am J Gastroenterol. 95:204–207. 2000.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou
Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, et
al: Intrahepatic cholangiocarcinoma: Rising frequency, improved
survival, and determinants of outcome after resection. Ann Surg.
248:84–96. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Farshidfar F, Zheng S, Gingras MC, Newton
Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J,
et al: Integrative genomic analysis of cholangiocarcinoma
identifies distinct IDH-Mutant molecular profiles. Cell Rep.
18:2780–2794. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Patel T: Worldwide trends in mortality
from biliary tract malignancies. BMC Cancer. 2(10)2002.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tang C, Jiang Y, Shao W, Shi W, Gao X, Qin
W, Jiang T, Wang F and Feng S: Abnormal expression of FOSB
correlates with tumor progression and poor survival in patients
with gastric cancer. Int J Oncol. 49:1489–1496. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Vierbuchen T, Ling E, Cowley CJ, Couch CH,
Wang X, Harmin DA, Roberts CWM and Greenberg ME: AP-1 transcription
factors and the BAF complex mediate signal-dependent enhancer
selection. Mol Cell. 68:1067:–1082.e12. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Iwaki J, Kikuchi K, Mizuguchi Y,
Kawahigashi Y, Yoshida H, Uchida E and Takizawa T: MiR-376c
down-regulation accelerates EGF-dependent migration by targeting
GRB2 in the HuCCT1 human intrahepatic cholangiocarcinoma cell line.
PLoS One. 8(e69496)2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47(D1):D607–D613.
2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Barrett CS, Millena AC and Khan SA: TGF-β
effects on prostate cancer cell migration and invasion require
FosB. Prostate. 77:72–81. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Becht E, McInnes L, Healy J, Dutertre CA,
Kwok IWH, Ng LG, Ginhoux F and Newell EW: Dimensionality reduction
for visualizing single-cell data using UMAP. Nat Biotechnol: Dec 3,
2018 (Epub ahead of print).
|
|
23
|
Ahmad SS, Basheer FT, Idris SF, Hariraj R,
Mathialagan R and Douds A: Cholangiocarcinoma presenting as
hemobilia and recurrent iron-deficiency anemia: A case report. J
Med Case Rep. 4(133)2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kim DS, Lee WK and Park JY: Association of
FOSB exon 4 unmethylation with poor prognosis in patients with
late-stage non-small cell lung cancer. Oncol Rep. 43:655–661.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hung YP, Fletcher CD and Hornick JL: FOSB
is a useful diagnostic marker for pseudomyogenic
hemangioendothelioma. Am J Surg Pathol. 41:596–606. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Alhendi AMN, Patrikakis M, Daub CO, Kawaji
H, Itoh M, de Hoon M, Carninci P, Hayashizaki Y, Arner E and
Khachigian LM: Promoter usage and dynamics in vascular smooth
muscle cells exposed to fibroblast growth factor-2 or
interleukin-1β. Sci Rep. 8(13164)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Van Doren SR: Matrix metalloproteinase
interactions with collagen and elastin. Matrix Biol. 44-46:224–231.
2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li H, Li L, Zheng H, Yao X and Zang W:
Regulatory effects of ΔFosB on proliferation and apoptosis of MCF-7
breast cancer cells. Tumour Biol. 37:6053–6063. 2016.PubMed/NCBI View Article : Google Scholar
|
